Pre-eclampsia Risk in Egg Recipients Study
Part of Blood & lymphatic, Cancer, Genetic & congenital, Heart & circulation, Hormones & metabolism, Immune system & allergy, Women’s health & pregnancy clinical trials.
This study looks at whether women who become pregnant after receiving donated eggs have a higher risk of developing pre-eclampsia (a serious blood pressure condition) during pregnancy. It aims to understand risks so doctors can better support pregnant women.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your BMI should be under 35.
- You must have had a normal vaginal swab test in the last three years.
- You can have had children before or not, and you can be pregnant with one or more babies.
- You cannot have certain health issues like HIV, hepatitis, high blood pressure, kidney disease, heart disease, or cancer (past or present).
- You cannot smoke, abuse alcohol or drugs, or be breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why women who use donated eggs may have a higher risk of preeclampsia (a pregnancy complication with high blood pressure) by examining specific genetic markers (HLA-C and KIR) in the mother, baby, and donor. By joining, you help researchers understand and potentially improve care for future mothers.
This trial studies ways to lower the risk of pre-eclampsia (dangerous high blood pressure in pregnancy) in women who are having a first pregnancy through IVF/ICSI or who have PCOS. It’s aimed at people considered higher risk for pre-eclampsia.
This study looks at how the body supports pregnancy in the early weeks and whether problems with that support can lead to complications. By tracking pregnancies from the start, researchers hope to find ways to predict and prevent issues like poor placental function.
This trial follows women who have had preeclampsia to learn more about their health after pregnancy. It collects blood and tissue samples to find markers that could improve future care.
This study tests a new medicine, EG-101, in healthy women to see if it is safe and to learn how the body processes it. This is a first step before studying it in pregnant women with severe pre-eclampsia, a serious condition of high blood pressure during pregnancy.
This study tests a blood-filtering device called KNP-1000 to see if it is safe for women with severe preeclampsia. It may help remove harmful substances from the blood and potentially improve outcomes for you and your baby.
Hear when a new Pre-Eclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.